Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vos

Showing results (551-560 of 566) with videos related to

Pageof 57
Sort By:
BMC Cancer|March 25, 2023
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastasesJ A Crouzen, A L Petoukhova, M L D Broekman, et al.
American Journal of Human Genetics|February 7, 2008
Structural variation of chromosomes in autism spectrum disorderChristian R Marshall, Abdul Noor, John B Vincent, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 26, 2015
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriersManon Suerink, Heleen M van der Klift, Sanne W Ten Broeke, et al.
Human Mutation|July 21, 2016
Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency SyndromeHeleen M van der Klift, Arjen R Mensenkamp, Mark Drost, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Nature Communications|June 30, 2019
Improving the diagnostic yield of exome- sequencing by predicting gene-phenotype associations using large-scale gene expression analysisPatrick Deelen, Sipko van Dam, Johanna C Herkert, et al.
Human Mutation|May 10, 2006
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic settingAnnemarie H van der Hout, Ans M W van den Ouweland, Rob B van der Luijt, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Trials|June 17, 2025
[<sup>18</sup>F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trialV J Ruijters, T J Snijders, J A J van der Pol, et al.
Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Pageof 57

Showing results (551-560 of 566) with videos related to

Sort By:
Pageof 57
BMC Cancer|March 25, 2023
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastasesJ A Crouzen, A L Petoukhova, M L D Broekman, et al.
American Journal of Human Genetics|February 7, 2008
Structural variation of chromosomes in autism spectrum disorderChristian R Marshall, Abdul Noor, John B Vincent, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 26, 2015
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriersManon Suerink, Heleen M van der Klift, Sanne W Ten Broeke, et al.
Human Mutation|July 21, 2016
Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency SyndromeHeleen M van der Klift, Arjen R Mensenkamp, Mark Drost, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Nature Communications|June 30, 2019
Improving the diagnostic yield of exome- sequencing by predicting gene-phenotype associations using large-scale gene expression analysisPatrick Deelen, Sipko van Dam, Johanna C Herkert, et al.
Human Mutation|May 10, 2006
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic settingAnnemarie H van der Hout, Ans M W van den Ouweland, Rob B van der Luijt, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Trials|June 17, 2025
[<sup>18</sup>F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trialV J Ruijters, T J Snijders, J A J van der Pol, et al.
Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Pageof 57